According to the IMARC Group, the anorexia market reached a value of US$ 88.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 556.6 Million by 2034, exhibiting a growth rate (CAGR) of 18.14% during 2024-2034. This can be attributed to the growing use of virtual reality therapy, which helps patients adopt more positive attitudes regarding food and their bodies by allowing them to face their worries in a safe setting.
Anorexia, or anorexia nervosa, is a complex as well as potentially life-threatening eating disorder defined by an intense dread of gaining weight, a distorted perception of one’s body, and a failure to maintain a healthy body weight. The anorexia market is growing steadily due to increasing awareness about eating disorders and their impact on health. Primarily, rising cases of anorexia, driven by societal pressures, genetic predispositions, and co-occurring psychiatric conditions such as anxiety and depression, are a major driver of market expansion. Furthermore, advancements in diagnostic tools, including psychological assessment scales and genetic testing, are enabling early and highly accurate diagnosis, boosting demand for effective treatments. In line with these factors, the anorexia market is witnessing significant development in pharmacological interventions aimed at managing symptoms and underlying psychological factors. These include antidepressants, antipsychotics, and emerging drugs targeting appetite regulation and mood stabilization. Additionally, the integration of cognitive-behavioral therapy (CBT), family-based therapy (FBT), and other evidence-based psychotherapies into treatment plans is enhancing recovery rates and long-term outcomes. Apart from this, the increasing use of digital health technologies, such as teletherapy and mobile applications for self-monitoring and support, is improving access to care and patient engagement. Consequently, the trend toward personalized medicine, leveraging individual psychological, genetic, and biological profiles to tailor interventions, is anticipated to drive growth in the anorexia market by offering more precise and effective treatment solutions in the coming years.
Request for a sample of this report: https://www.imarcgroup.com/anorexia-market/requestsample
Countries Covered:
• United States
• Germany
• France
• United Kingdom
• Italy
• Spain
• Japan
Analysis Covered Across Each Country:
• Historical, current, and future epidemiology scenario
• Historical, current, and future performance of the Anorexia Market
• Historical, current, and future performance of various therapeutic categories in the market
• Sales of various drugs across the Anorexia Market
• Reimbursement scenario in the market
• In-market and pipeline drugs
This report also provides a detailed analysis of the current anorexia marketed drugs and late-stage pipeline drugs.
In-Market Drugs:
• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Drug Uptake and Market Performance
Late-Stage Pipeline Drugs:
• Drug overview
• Mechanism of action
• Regulatory status
• Clinical trial results
• Drug uptake and market performance
Competitive Landscape with key players:
The competitive landscape of the Anorexia Market has been studied in the report with the detailed profiles of the key players operating in the market.
- COMPASS Pathways
Ask the Analyst for Customization and Explore the Full Report with TOC: https://www.imarcgroup.com/request?type=report&id=8697&flag=A
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
Market Outlook 